These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 513391)

  • 1. [Studies on estrogen in human male plasma. III. Plasma peptide and steroid hormone levels in patients with prostatic cancer and renal cell carcinoma (author's transl)].
    Ohashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 Aug; 70(8):928-40. PubMed ID: 513391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on estrogen in human males. I. Plasma estrogen levels in normal men, castrated men and patients with liver cirrhosis and renal insufficiency (author's transl)].
    Ohashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 Aug; 70(8):904-14. PubMed ID: 513390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on estrogen in human males. II. Plasma estrogen response to synthetic ACTH and HCG stimulation in normal men and patients with hypogonadism (author's transl)].
    Ohashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 Aug; 70(8):915-27. PubMed ID: 229288
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormones in renal cancer.
    Sufrin G; Mirand EA; Moore RH; Chu TM; Murphy GP
    Trans Am Assoc Genitourin Surg; 1976; 68():115-20. PubMed ID: 1030544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrinological studies on prostatic carcinoma. 1. Plasma hormone profiles in patients with prostatic carcinoma (author's transl)].
    Morioka M
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):953-66. PubMed ID: 6459486
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].
    Bülow H; Wullstein HK; Böttger G; Schröder FH
    Urologe A; 1973 Sep; 12(5):249-53. PubMed ID: 4357698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer of the breast in patients having prostatic cancer treated with estrogens. Report of three cases (author's transl)].
    Dore B; Dombriz M; Denis P; Darracq-Paries JC; Barbier J; Aubert J
    J Urol (Paris); 1982; 88(4):247-52. PubMed ID: 7108255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and steroid-dependent carcinomas.
    Oosthuizen JM; Bornman MS; Barnard HC; Schulenburg GW; Boomker D; Reif S
    Andrologia; 1989; 21(5):429-31. PubMed ID: 2817446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone therapy of prostatic cancer (author's transl)].
    Altwein JE; Jacobi GH
    Urologe A; 1980 Nov; 19(6):350-7. PubMed ID: 7193368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in serum haptoglobin in patients with renal cell carcinoma (author's transl)].
    Sasaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jan; 68(1):50-8. PubMed ID: 321841
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)].
    Faul P; Schmiedt E; Kern R
    Urologe A; 1978 Nov; 17(6):377-81. PubMed ID: 726160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coincidence of two carcinomata with excessive high level of serumestrogen (author's transl)].
    Steldinger R; Schmidt L; Schmidt-Gollwitzer M; Eber H; Iglesias JR; Frisius H
    Med Klin; 1976 Oct; 71(41):1717-9. PubMed ID: 979872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematological variables in prostatic carcinoma patients.
    Geenen RW; Delaere KP; van Wersch JW
    Acta Urol Belg; 1996 Sep; 64(3):21-6. PubMed ID: 8946777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal changes in prostatic hypertrophy and cancer].
    Baranowska B; Zgliczyński S; Szymanowski J
    Endokrynol Pol; 1981; 32(4):319-31. PubMed ID: 6171423
    [No Abstract]   [Full Text] [Related]  

  • 15. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sexual hormone on the human mammary carcinoma cells in vitro (author's transl)].
    Mishima I
    Yonago Acta Med; 1973 Sep; 17(2):123-32. PubMed ID: 4367573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
    Taplin ME; George DJ; Halabi S; Sanford B; Febbo PG; Hennessy KT; Mihos CG; Vogelzang NJ; Small EJ; Kantoff PW
    Urology; 2005 Aug; 66(2):386-91. PubMed ID: 16098367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma hormone levels before and after orchiectomy in prostate cancer patients.
    Fiet J; Villette JM; Bertagna C; de Géry A; Hucher M; Husson JM; Raynaud JP
    Prog Clin Biol Res; 1987; 243A():33-44. PubMed ID: 3659004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma estrogen level in patients with cervical cancer].
    Zheng Y
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):404-5. PubMed ID: 2076633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.